UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
ATXS holding history
Astria Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATXS overviewAll 13F holders of ATXSFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −2,399,171−100.0% | Sold out | Holders |
| Q4 2025 | 2,399,171 | $31.4M | <0.1% | +1,819,020+313.5% | Added | Holders |
| Q3 2025 | 580,151 | $4.22M | <0.1% | −132,101−18.5% | Reduced | Holders |
| Q2 2025 | 712,252 | $3.82M | <0.1% | −531,224−42.7% | Reduced | Holders |
| Q1 2025 | 1,243,476 | $6.64M | <0.1% | −122,516−9.0% | Reduced | Holders |
| Q4 2024 | 1,365,992 | $12.2M | <0.1% | +1,305,907+2,173.4% | Added | Holders |
| Q3 2024 | 60,085 | $661.5K | <0.1% | −5,589−8.5% | Reduced | Holders |
| Q2 2024 | 65,674 | $597.6K | <0.1% | −60,374−47.9% | Reduced | Holders |
| Q1 2024 | 126,048 | $1.77M | <0.1% | +89,876+248.5% | Added | Holders |
| Q4 2023 | 36,172 | $277.8K | <0.1% | +23,245+179.8% | Added | Holders |
| Q3 2023 | 12,927 | $96.4K | <0.1% | −1,859−12.6% | Reduced | Holders |
| Q2 2023 | 14,786 | $123.2K | <0.1% | +12,114+453.4% | Added | Holders |
| Q1 2023 | 2,672 | $35.5K | <0.1% | +2,668+66,700.0% | Added | Holders |
| Q4 2022 | 4 | $60 | <0.1% | −3,258−99.9% | Reduced | Holders |
| Q3 2022 | 3,262 | $29.0K | <0.1% | +3,237+12,948.0% | Added | Holders |
| Q2 2022 | 25 | $0 | 0.0% | +25 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −3,247−100.0% | Sold out | Holders |
| Q4 2021 | 3,247 | $18.0K | <0.1% | +239+7.9% | Added | Holders |
| Q3 2021 | 3,008 | $27.0K | <0.1% | +3,008 | New | Holders |